Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia. Studies of newly diagnosed dementia are required in order to establish whether the elevated homocysteine levels precede the onset of dementia or result from dementia-related nutritional and vitamin deficiencies. METHODS: A total of 1092 subjects without dementia (667 women and 425 men; mean age, 76 years) from the Framingham Study constituted our study sample. We examined the relation of the plasma total homocysteine level measured at base line and that measured eight years earlier to the risk of newly diagnosed dementia on follow-up. We used multivariable proportional-hazards regression to adjust for age, sex, apolipoprotein E genotype, vascular risk factors other than homocysteine, and plasma levels of folate and vitamins B12 and B6. RESULTS: Over a median follow-up period of eight years, dementia developed in 111 subjects, including 83 given a diagnosis of Alzheimer's disease. The multivariable-adjusted relative risk of dementia was 1.4 (95 percent confidence interval, 1.1 to 1.9) for each increase of 1 SD in the log-transformed homocysteine value either at base line or eight years earlier. The relative risk of Alzheimer's disease was 1.8 (95 percent confidence interval, 1.3 to 2.5) per increase of 1 SD at base line and 1.6 (95 percent confidence interval, 1.2 to 2.1) per increase of 1 SD eight years before base line. With a plasma homocysteine level greater than 14 micromol per liter, the risk of Alzheimer's disease nearly doubled. CONCLUSIONS: An increased plasma homocysteine level is a strong, independent risk factor for the development of dementia and Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adjudication for Alzheimer’s phenotypes was done by a committee41, comprising at least two neurologists and a neuropsychologist.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [41]
In the citing paper
“Dementia diagnoses were made according to DSM‐IV criteria, based on longitudinal cognitive assessments, caregiver interviews, medical records, neuroimaging, and autopsy data when available.”
From Blood PCSK9 Impacts Alzheimer's Disease Risk in an APOE Genotype‐Dependent Manner: A Prospective Cohort Study (2026) · cites this paper as [18]
In the citing paper
“Overall, of the 19 selected cohort studies linking Hcy to the various cognitive outcomes, 12(63.2%) found the relationship in the hypothesized direction in the entire population that was studied and for most outcomes of interest [206,215,217,219,222-224,228,231,233-235]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [206]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Self-citationBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Research works printed but not linked: 3
- Berg L, 1988, Psychopharmacol Bull, 24, 637
- Levin ML, 1953, Acta Unio Int Contr Cancrum, 9, 531
- 1996, Fed Regist, 61, 8781
Cited by
Items 601–700 of 1,022
Alzheimer’s disease and total plasma aminothiols
McCaddon, A., Hudson, P. R., Hill, D., Barber, J., Lloyd, A., Davies, G. K., & Regland, B. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01451-8 · Cited by 89
Zhuo, J.-M., & Praticò, D. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2009.12.005 · Cited by 89
“In addition to these cardiovascular diseases, HHcy has been recently found to be involved in the development of neurodegenerative diseases such as Alzheimer's disease (AD) (Clarke et al., 1998;Leblhuber et al., 2000;Seshadri et al., 2002).”
BackgroundInfluentialLautenschlager, N. T., Flicker, L. A., Vasikaran, S. D., Leedman, P. J., & Almeida, O. P. (2005) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200508000-00013 · Cited by 95
Homocysteine as a neurotoxin in chronic alcoholism
Bleich, S., Degner, D., Sperling, W., Bönsch, D., Thürauf, N., & Kornhuber, J. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.11.019 · Cited by 94
“Homocysteine is a simple sulphur-containing amino acid that has recently received a great deal of attention for atherothrombic vascular as well as for neurodegenerative diseases such as Alzheimer’s disease (Seshadri et al., 2002).”
BackgroundLu, C., Zu, Y., & Yam, V. W. (2006) · Analytical Chemistry · doi:10.1021/ac061513c · Cited by 88
Hankey, G. J., Ford, A. H., Yi, Q., Eikelboom, J. W., Lees, K. R., Chen, C., Xavier, D., Navarro, J. C., Ranawaka, U. K., Uddin, W., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.001886 · Cited by 88
Bearden, S. E., Beard, R. S., & Pfau, J. C. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00555.2010 · Cited by 93
Rai, V. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9722-8 · Cited by 88
“Numerous epidemiological and experimental studies have linked folate deficiency and resultant increased homocysteine levels with AD [5].”
BackgroundPark, S.-S., Park, H.-S., Kim, C., Kang, H., Kim, D., Baek, S., & Kim, T.-W. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00631-4 · Cited by 98
Weisfeld‐Adams, J. D., Bender, H. A., Miley-Åkerstedt, A., Frempong, T. A., Schrager, N. L., Patel, K., Naidich, T. P., Stein, V., Spat‐Lemus, J., Towns, S. J., et al. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.07.018 · Cited by 98
Chan, A., Tchantchou, F., Graves, V., Rozen, R. R., & Shea, T. B. (2008) · The journal of nutrition health & aging · doi:10.1007/bf02982630 · Cited by 91
“Folate deprivation leads to age-related neurodegenerative disorders including Alzheimer’s disease (AD; 2). Folate deficiency fosters a decline in S-adenosyl methionine (SAM; the major methyl donor), decreasing DNA methylation during aging and AD (3, 4 ) and increasing DNA breakage (5, 6). Folate deficiency and resulta…”
Reif, A., Pfuhlmann, B., & Lesch, K. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.06.027 · Cited by 91
“The largest study derived from the seminal Framingham study data set and included a cross-sectional sample of 1092 subjects: when plasma HCY was elevated above 14 Amol/l, the risk for AD was almost doubled (Seshadri et al., 2002).”
Lovell, M. A. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0992 · Cited by 87
“], hyperlipidemia [23], hypertension [24], heart disease [25], smoking [26,27], elevated plasma homo-cysteine [28], and obesity [29].”
Mosconi, L., Murray, J., Davies, M., Williams, S., Pirraglia, E., Spector, N., Tsui, W. H., Li, Y., Butler, T., Osorio, R. S., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004850 · Cited by 87
DNA-stabilized bimetallic nanozyme and its application on colorimetric assay of biothiols
Sun, Y., Wang, J., Li, W., Zhang, J., Zhang, Y., & Fu, Y. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.08.001 · Cited by 87
“Hcy at a high level is associated with cardiovascular and Alzheimer’s diseases (Aguilar et al. 2004; Andreotti et al. 2000; Lee and Cheon 2011; Seshadri et al. 2002).”
BackgroundAlzheimer's Disease: Cerebrovascular Dysfunction, Oxidative stress, and Advanced Clinical Therapies
Marlatt, M. W., Lucassen, P. J., Perry, G. L., Smith, M. A., & Zhu, X. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15206 · Cited by 97
“Turn-on” FRET-based luminescent iridium(iii) probes for the detection of cysteine and homocysteine
Shiu, H., Wong, M., & Che, C. (2011) · Chemical Communications · doi:10.1039/c0cc04288a · Cited by 87
Chertkow, H. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.070795 · Cited by 86
Urinary Excretion of Homocysteine-Thiolactone in Humans
Chwatko, G., & Jakubowski, H. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.042531 · Cited by 89
“Plasma tHcy is also a risk factor for neurodegenerative disorders, including dementia and Alzheimer disease ( 3 ).”
Vascular factors in dementia: an overview
DeCarli, C. S. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.005 · Cited by 95
Protein N-homocysteinylation: From cellular toxicity to neurodegeneration
Sharma, G. S., Kumar, T., Dar, T. A., & Singh, L. R. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.08.013 · Cited by 93
“have shown that an increased concentration of Hcy in the blood is a strong indicator for AD [28].”
BackgroundHighly selective phosphorescent nanoprobes for sensing and bioimaging of homocysteine and cysteine
Liu, X., Xi, N., Liu, S., Ma, Y., Yang, H., Li, H., He, J., Zhao, Q., Li, F., & Huang, W. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm15946e · Cited by 86
Folate and Alzheimer: when time matters
Hinterberger, M., & Fischer, P. A. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0822-y · Cited by 97
Chen, Z., Sun, Q., Yao, Y., Fan, X., Zhang, W., & Qian, J. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.01.013 · Cited by 86
Yang, Z., Huang, S., Zhong, K., Huang, W., Huang, Z.-H., He, T., Yang, M.-T., Wusiman, M., Zhou, D.-D., Chen, S., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103026 · Cited by 96
“Moreover, epidemiological evidence has found that elevated plasma total homocysteine (Hcy) is a modifiable risk factor for dementia in older adults [8 – 10].”
BackgroundA review of genome mutation and Alzheimer's disease
Thomas, P., & Fenech, M. F. (2006) · Mutagenesis · doi:10.1093/mutage/gel055 · Cited by 110
Homocysteine and cognition: A systematic review of 111 studies
Setién‐Suero, E., Suárez‐Pinilla, M., Suárez‐Pinilla, P., Crespo‐Facorro, B., & Ayesa‐Arriola, R. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.014 · Cited by 101
Womack, K. B., Diaz-Arrastia, R., Aizenstein, H. J., Arnold, S. E., Barbas, N. R., Boeve, B. F., Clark, C. M., DeCarli, C. S., Jagust, W. J., Leverenz, J. B., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.295 · Cited by 85
“Voxel-based morphometric analysis of structural magnetic resonance imaging can detect differences in regional atrophy between groups of patients with FTLD, FTLD subtypes, and AD and controls.(34,35) However, visual interpretation of individual magnetic resonance imaging scans, while helpful, can be misleading.”
BackgroundChanges in folate, vitamin B12 and homocysteine associated with incident dementia
Kim, J.-M., Stewart, R., Kim, S.-W., Shin, I.-S., Yang, S.-J., Shin, H.-Y., & Yoon, J.-S. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131482 · Cited by 85
“(7) Model 6 plus baseline body weight 1.”
BackgroundNutritional supplementation and dietary advice in geriatric patients at risk of malnutrition
Persson, M., Hytter-Landahl, Å., Brismar, K., & Cederholm, T. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2006.12.002 · Cited by 85
“17 5–20 S-Folate (mol/l) 8 [6–12] 13 [10–23]* 8[6–10.”
InfluentialHydrogen Sulfide Deactivates Common Nitrobenzofurazan-Based Fluorescent Thiol Labeling Reagents
Montoya, L. A., & Pluth, M. D. (2014) · Analytical Chemistry · doi:10.1021/ac501193r · Cited by 85
Lu, Q., Wang, H., Liu, Y., Hou, Y., Li, H., & Zhang, Y. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.05.064 · Cited by 84
Wang, K., Leng, T., Liu, Y., Wang, C., Shi, P., Shen, Y., & Zhu, W. (2017) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2017.03.127 · Cited by 85
Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease
Collins, A. E., Saleh, T. M., & Kalisch, B. E. (2022) · Antioxidants · doi:10.3390/antiox11020213 · Cited by 102
Left Ventricular Mass, Blood Pressure, and Lowered Cognitive Performance in the Framingham Offspring
Elias, M. F., Sullivan, L. M., Elias, P. K., D’Agostino, R. B., Wolf, P. A., Seshadri, S., Au, R., Benjamin, E. J., & Vasan, R. S. (2007) · Hypertension · doi:10.1161/01.hyp.0000256361.68158.24 · Cited by 84
Self-citationDelayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia
Cole, P. D., & Kamen, B. A. (2006) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20113 · Cited by 94
Low vitamin B-12 status in confirmed Alzheimer's disease as revealed by serum holotranscobalamin
Refsum, H. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.959 · Cited by 86
Determining bioavailability of food folates in a controlled intervention study
Hannon-Fletcher, M. P. A., Armstrong, N., Scott, J. M., Pentieva, K. D., Bradbury, I., Ward, M., Strain, J., Dunn, A., Molloy, A. M., Kerr, M. A., et al. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.4.911 · Cited by 108
“Folate is attracting considerable interest as having an established role in the prevention of neural tube defects (NTDs; 1, 2) and possible preventive roles against cardiovascular disease (3), certain cancers (4), and neuropsychiatric conditions (5).”
BackgroundWang, K., Qian, J., Jiang, D., Yang, Z., Du, X., & Wang, K. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.09.093 · Cited by 84
Das, P., Mandal, A. K., Chandar, N. B., Baidya, M., Bhatt, H. B., Ganguly, B., Ghosh, S. K., & Das, A. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201201621 · Cited by 85
Management of mild to moderate Alzheimer's disease and dementia
Hogan, D. B., Bailey, P., Carswell, A., Clarke, B., Cohen, C., Forbes, D., Man‐Son‐Hing, M., Lanctôt, K., Morgan, D., & Thorpe, L. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.07.006 · Cited by 84
“[90] Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH,”
BackgroundThe betaine content of New Zealand foods and estimated intake in the New Zealand diet
Slow, S., Donaggio, M., Cressey, P. J., Lever, M., George, P. M., & Chambers, S. T. (2005) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2004.05.004 · Cited by 89
Current Treatment and Recent Clinical Research in Alzheimer's Disease
Neugroschl, J., & Sano, M. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20165 · Cited by 84
Tonic Dopaminergic Stimulation Impairs Associative Learning in Healthy Subjects
Breitenstein, C., Korsukewitz, C., Flöel, A., Kretzschmar, T., Diederich, K., & Knecht, S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301167 · Cited by 93
“…for extended time periods in Parkinson’s disease (Curran and Perry, 2004) and to have less adverse effects like dyskinesias, psychosis, or hyperhomocysteinemia, a risk factor for cardiovascular disease and dementia (Jankovic, 2002; Miller et al, 2003; Rogers et al, 2003; Seshadri et al, 2002).”
BackgroundAlirezaei, M., Khoshdel, Z., Dezfoulian, O., Rashidipour, M., & Taghadosi, V. (2015) · The Journal of Physiological Sciences · doi:10.1007/s12576-015-0360-0 · Cited by 91
“In this sense, Hcy is considered as a predictor for dementia and Alzheimer’s disease [13, 19, 20].”
BackgroundGene silencing through methylation: An epigenetic intervention on Alzheimer disease
Scarpa, S., Cavallaro, R. A., D'Anselmi, F., & Fuso, A. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9406 · Cited by 84
Sun, B., Zhang, K., Chen, L., Guo, L., & Ai, S. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.01.014 · Cited by 83
“Furthermore, the detection limit was much less than the normal level of cysteine in human plasma (240–360 mM) (Seshadri et al., 2002) and was also less an order of magnitude than that of previous work (Tu et al., 2011).”
ResultVascular dementia: From pathobiology to emerging perspectives
Morgan, A. E., & Auley, M. T. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102278 · Cited by 116
“This is pathologically significant because elevated Hcy is associated with several age-related diseases, including coronary artery disease (Shenoy et al., 2014), stroke (Shi et al., 2015), AD (Seshadri et al., 2002), and VaD (Nilsson et al., 2013; Ravaglia et al., 2005).”
BackgroundKwok, T. C. Y., Lee, J.-H., Law, C. B., Pan, P. C., Yung, C. Y., Choi, K. C., & LAM, L. C. W. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2010.12.004 · Cited by 90
Lu, C., & Zu, Y. (2007) · Chemical Communications · doi:10.1039/b708603b · Cited by 83
Fazili, Z., & Pfeiffer, C. M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.036541 · Cited by 89
Scott, T. M., Tucker, K. L., Bhadelia, A., Benjamin, B., Patz, S., Bhadelia, R. A., Liebson, E. S., Price, L. L., Griffith, J., Rosenberg, I. H., et al. (2004) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.12.6.631 · Cited by 88
Self-citationA Selective Glutathione Probe based on AIE Fluorogen and its Application in Enzymatic Activity Assay
Lou, X., Hong, Y., Chen, S., Leung, C. W. T., Zhao, N., Situ, B., Lam, J. W. Y., & Tang, B. Z. (2014) · Scientific Reports · doi:10.1038/srep04272 · Cited by 83
In Vitro and in Vivo Interactions of Homocysteine with Human Plasma Transthyretin
Lim, A., Sengupta, S., McComb, M. E., Théberge, R., Wilson, W. G., Costello, C. E., & Jacobsen, D. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306748200 · Cited by 83
The neurobiology of neuropsychiatric syndromes in dementia
Meeks, T. W., Ropacki, S. A., & Jeste, D. V. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000245746.45384.0e · Cited by 83
Xu, J., Yu, H., Hu, Y., Chen, M., & Shao, S. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.08.007 · Cited by 85
Bénétos, A., Watfa, G., Hanon, O., Salvi, P., Fantin, F., Toulza, O., Manckoundia, P., Agnoletti, D., Labat, C., & Gautier, S. (2010) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2010.08.014 · Cited by 94
Vance, D. E., Li, Z., & Jacobs, R. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700028200 · Cited by 86
Folate Intake and Risk of Parkinson's Disease
Chen, H. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh213 · Cited by 82
“In the Framingham Cohort Study (3), individuals with plasma homocysteine greater than 14.0 µmol per liter had 90 percent higher risk of Alzheimer’s disease compared with those with normal concentrations.”
InfluentialKuo, H.-K., Liao, K.-C., Leveille, S. G., Bean, J. F., Yen, C.-J., Chen, J.-H., Yu, Y.-H., & Tai, T.-Y. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.4.434 · Cited by 82
“Abundant data support the notion that elevated homocysteine levels are linked to several multisystem geriatric problems (6), including dementia and Alzheimer’s disease (7), osteoporotic fracture (8,9), and decline in physical function (10).”
BackgroundBioactive Components in Camel Milk
El‐Agamy, E. I. (2009) · Wiley eBooks · doi:10.1002/9780813821504.ch6 · Cited by 120
Cognitive Impairment and Dementia in Older Adults With Chronic Kidney Disease: A Review
Zammit, A. R., Katz, M. J., Bitzer, M., & Lipton, R. B. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000178 · Cited by 81
Qi, F., Zhang, Y., Wang, B., Chen, W., Yang, L., Yang, Z., & Song, X. (2019) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2019.05.010 · Cited by 81
Vitamin B12 in neurology and ageing; Clinical and genetic aspects
McCaddon, A. (2012) · Biochimie · doi:10.1016/j.biochi.2012.11.017 · Cited by 100
Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications
Zoccolella, S., Lamberti, P., Armenise, E., Mari, M. D., Lamberti, S. V., Mastronardi, R., Fraddosio, A., Iliceto, G., & Livrea, P. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.07.008 · Cited by 81
“Homocysteine (Hcy) is a well known risk factor for vascular diseases (as cardiac, cerebral and peripheral vascular diseases and venous thrombosis), cognitive impairment and dementia [1–4].”
BackgroundLacut, K., Gal, G. L., Couturaud, F., Cornily, G., Leroyer, C., Mottier, D., & Oger, E. (2007) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00515.x · Cited by 84
Atrial Fibrillation Is Associated With Lower Cognitive Performance in the Framingham Offspring Men
Elias, M. F., Sullivan, L. M., Elias, P. K., Vasan, R. S., D’Agostino, R. B., Seshadri, S., Au, R., Wolf, P. A., & Benjamin, E. J. (2006) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2006.05.009 · Cited by 80
Self-citationA label-free method for detecting biothiols based on poly(thymine)-templated copper nanoparticles
Zhang, L., Cai, Q., Li, J., Ge, J., Wang, J., Dong, Z., & Li, Z. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.02.012 · Cited by 80
Joshi, S., Shenoy, D., Vibhudendra Simha, G. G., Rrashmi, P. L., Venugopal, K. R., & Patnaik, L. M. (2010) · International Conference on Machine Learning and Computing (ICMLC) · doi:10.1109/icmlc.2010.45 · Cited by 103
“The prevalence of Alzheimer disease (AD) and Parkinson’s disease is increasing in the elderly [3].”
BackgroundHomocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer’s disease
Anello, G., Guéant-Rodríguez, R.-M., Bosco, P., Guéant, J.-L., Romano, A., Namour, B., Spada, R., Caraci, F., Pourié, G., Daval, J.-L., et al. (2004) · NeuroReport · doi:10.1097/00001756-200404090-00025 · Cited by 80
Yulug, B., Altay, O., Li, X., Hanoglu, L., Cankaya, S., Lam, S., Velioglu, H. A., Yang, H., Coskun, E., Idil, E., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00336-2 · Cited by 79
“In addition, decreased histidine metabolism and other decreased markers, such as homocysteine and S-adenosylhomocysteine found in our treatment group, have been shown to slow the cognitive ageing process when appropriately downregulated [127].”
BackgroundDNA methylation alterations in Alzheimer’s disease
Yokoyama, A. S., Rutledge, J. C., & Medici, V. (2017) · Environmental Epigenetics · doi:10.1093/eep/dvx008 · Cited by 96
Low Vitamin B12 Levels: An Underestimated Cause Of Minimal Cognitive Impairment And Dementia
Jatoi, S., Hafeez, D. A., Riaz, S. U., Ali, A., Ghauri, M. I., & Zehra, M. (2020) · Cureus · doi:10.7759/cureus.6976 · Cited by 110
“Elevated homocysteine levels may be associated with Alzheimer’s disease, cardiovascular disease, and stroke [2-4].”
BackgroundMadziva, H., Kailasapathy, K., & Phillips, M. (2005) · LWT · doi:10.1016/j.lwt.2004.12.015 · Cited by 79
“There are also indications for positive effects of a good folate status for cognitive functions (Seshadri et al., 2002) and on prevention of certain forms of cancer (Giovannucci et al.”
BackgroundKłapcińska, B., Poprzęcki, S., Danch, A., Sobczak, A., & Kempa, K. (2005) · Biological Trace Element Research · doi:10.1385/bter:108:1-3:001 · Cited by 91
“During recent years, the evidence has accumulated that elevated pHcy concentrations are associated with occlusive disease in the coronary, cerebral, and peripheral arteries (14,15).”
Schwab, U., Törrönen, A., Meririnne, E., Saarinen, M., Alfthan, G., Aro, A., & Uusitupa, M. I. J. (2006) · Journal of Nutrition · doi:10.1093/jn/136.1.34 · Cited by 79
“However, it is a marker of the risk of thrombosis and might have a role in the progression of Alzheimer’s disease (6).”
BackgroundXie, Y., Feng, H., Peng, S., Xiao, J., & Zhang, J. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.11.007 · Cited by 79
Reduced plasma homocysteine levels in levodopa/entacapone treated Parkinson patients
Valkovič, P., Benetin, J., Blažíček, P., Valkovičová, L., Gmitterová, K., & Kukumberg, P. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.01.007 · Cited by 79
“There is growing evidence that an elevated plasma concentration of homocysteine (hyperhomocysteinemia) is also associated with higher risk for cognitive impairment, including that seen in Alzheimer’s disease [22].”
BackgroundTotal homocysteine and cognition in a tri-ethnic cohort: The Northern Manhattan Study
Wright, C. B., Lee, H. S., Paik, M. C., Stabler, S. P., Allen, R. H., & Sacco, R. L. (2004) · Neurology · doi:10.1212/01.wnl.0000129986.19019.5d · Cited by 79
Goswami, S., Manna, A., Paul, S., Das, A. K., Nandi, P. K., Maity, A. K., & Saha, P. (2013) · Tetrahedron Letters · doi:10.1016/j.tetlet.2013.11.055 · Cited by 78
Cognitive impairment after cerebrovascular stroke: Relationship to vascular risk factors
Hamed, S. A. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s4184 · Cited by 93
“In addition, information has been emerging regarding a connection between Hcy metabolism and cognitive function, from mild cognitive decline to vascular dementia and AD.(4,16) Only very few data are available regarding the direct impact of Hcy on cognitive in stroke patients.”
InfluentialMelse‐Boonstra, A., Holm, P. I., Ueland, P. M., Olthof, M. R., Clarke, R., & Verhoef, P. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.6.1378 · Cited by 85
Yang, X., Guo, Y., & Strongin, R. M. (2011) · Angewandte Chemie · doi:10.1002/ange.201103759 · Cited by 79
Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease
Malaguarnera, M., Ferri, R., Bella, R., Alagona, G., Carnemolla, A., & Pennisi, G. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.208 · Cited by 77
“An increased plasma Hcy level is a strong, independent risk factor for the development of dementia and AD (17).”
BackgroundMidlife homocysteine and late-life dementia in women. A prospective population study
Zylberstein, D. E., Lissner, L., Björkelund, C., Mehlig, K., Thelle, D. S., Gustafson, D., Östling, S., Waern, M., Guo, X., & Skoog, I. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.024 · Cited by 76
Lo, K. K., & Tso, K. K. (2015) · Inorganic Chemistry Frontiers · doi:10.1039/c5qi00002e · Cited by 85
Vascular risk factors and dementia in the general population aged >85 years
Rastas, S., Pirttilä, T., Mattila, K. J., Verkkoniemi, A., Juva, K., Niinistö, L., Länsimies, E., & Sulkava, R. O. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.020 · Cited by 88
Choe, Y. M., Sohn, B. K., Choi, H. J., Byun, M. S., Seo, E. H., Han, J., Kim, Y. K., Yoon, E. J., Lee, J. M., Park, J., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.013 · Cited by 77
“A series of studies also suggested that the elevation of plasma total homocysteine (tHcy) increases the risk of cognitive decline, dementia, and Alzheimer’s disease (AD) (Nurk et al., 2005; Prins et al., 2002; Ravaglia et al., 2005; Seshadri et al., 2002).”
BackgroundElectrochemical Detection of Glutathione Using Redox Indicators
Pacsial-Ong, E. J., McCarley, R. L., Wang, W., & Strongin, R. M. (2006) · Analytical Chemistry · doi:10.1021/ac061451q · Cited by 78
Hermann, B. P., Seidenberg, M., Sager, M. A., Carlsson, C. M., Gidal, B. E., Sheth, R. D., Rutecki, P. A., & Asthana, S. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2007.01435.x · Cited by 82
“…et al., 1999; Hankey & Eikelboom, 1999; Wald et al., 2002; Refsum et al., 2006), and prospective research has demonstrated its association with cognitive decline (McCaddon et al., 2001; Dufouil et al., 2003) and dementia (Seshadri et al., 2002; Luchsinger et al., 2004; Ravaglia et al., 2005).”
BackgroundRapid measurement of total plasma homocysteine by HPLC
Frick, B., Schröcksnadel, K., Neurauter, G., Wirleitner, B., Artner‐Dworzak, E., & Fuchs, D. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00076-7 · Cited by 76
Meta-analysis of the relationship between homocysteine, vitamin B12, folate, and multiple sclerosis
Zhu, Y., He, Z.-Y., & Liu, H.-N. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2010.12.022 · Cited by 75
The Effects of Multivitamins on Cognitive Performance: A Systematic Review and Meta-Analysis
Grima, N. A., Pase, M. P., Macpherson, H., & Pipingas, A. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-111751 · Cited by 75
“Elevated plasma concentrations of homocysteine, a nonproteinogenic amino acid, have previously been associated with the development of dementia [26] as well as decline in recall memory [27].”
A coumarin-based fluorescent probe for biological thiols and its application for living cell imaging
Long, L., Zhou, L., Wang, L., Meng, S., Gong, A., Du, F., & Chi Zhang, A. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob41741g · Cited by 75
Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer’s Disease
Sheng, M., Lu, H., Liu, P., Li, Y., Ravi, H., Peng, S.-L., Diaz-Arrastia, R., Devous, M. D., & Womack, K. B. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161006 · Cited by 75
“Epidemiologic studies have shown that AD and vascular disease share many risk factors including hypertension, diabetes, hyperhomocysteinemia, obesity, and hyperlipidemia [5–7].”
Zhang, J., Ji, X., Ren, H., Zhou, J., Chen, Z., Dong, X., & Zhao, W. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.01.016 · Cited by 75
ESIPT-based fluorescence probe for the rapid detection of peroxynitrite ‘AND’ biological thiols
Wu, L., Han, H., Liu, L., Gardiner, J. E., Sedgwick, A. C., Huang, C., Bull, S. D., He, X., & James, T. D. (2018) · Chemical Communications · doi:10.1039/c8cc06917d · Cited by 75
Guo, T., Chen, X., Qu, W., Yang, B., Tian, R., Geng, Z., & Wang, Z. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04895 · Cited by 74
Homocysteine Lowering and Cognition in CKD: The Veterans Affairs Homocysteine Study
Brady, C. B., Gaziano, J. M., Cxypoliski, R. A., Guarino, P. D., Kaufman, J. S., Warren, S. R., Hartigan, P., Goldfarb, D. S., & Jamison, R. L. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.05.013 · Cited by 75
Wang, X.-L., Zeng, J., Feng, J., Tian, Y.-T., Liu, Y.-J., Qiu, M., Yan, X., Yang, Y., Xiong, Y., Zhang, Z.-H., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00066 · Cited by 74
Metadata
- Authors
- Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A.
- Affiliations
- Boston University (US)
- Tufts University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-02-14
- Volume
- 346
- Issue
- 7
- Pages
- 476-483
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2052588755
- Cited by
- 3,237
- References
- 55
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 82 · 2023: 79 · 2022: 90 · 2021: 102 · 2020: 91 · 2019: 133 · 2018: 132 · 2017: 138 · 2016: 138 · 2015: 149 · 2014: 174 · 2013: 154 · 2012: 155
- FWCI
- 111.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc038038-022)
- National Institute on Aging (5R01 AG 08122-11, 5R01-AG16495-02, R01AG016495, R01AG008122)
- National Heart, Lung, and Blood Institute (N01-HC-38038)
- National Institute of Neurological Disorders and Stroke (5R01 NS 17950-19, R01NS017950)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- plasma homocysteine, dementia, Alzheimer's disease, risk factors, newly diagnosed dementia, folic acid, vitamin B12, vitamin B6, apolipoprotein E, Framingham Heart Study, cognitive decline
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Dementia, Female, Homocysteine, Humans, Male, Risk Factors, Cohort Studies, Confounding Factors, Epidemiologic, Multivariate Analysis, Proportional Hazards Models, Hyperhomocysteinemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.